跳至主要内容
临床试验/CTRI/2025/02/079876
CTRI/2025/02/079876尚未招募不适用

Effectiveness of individualised homoeopathic medicine on patients of irritable bowel syndrome with history of adverse parenting An open label prospective clinical study.

Dr Shubhranil Mandal1 个研究点 分布在 1 个国家目标入组 45 人开始时间: 2025年2月10日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
45
试验地点
1
主要终点
IBS SEVERITY SCORING SYSTEM

研究概览

简要总结

With research question of does individualized homoeopathic medicine have any significant effect on patients suffering from IBS reflected with history of adverse parenting the study has been proposed.

Null Hypothesis:

There is no significant change in IBS - Severity Score Scale (IBSSSS) using individu-alized homoeopathic medicine in patients of IBS with a history of adverse parenting.

Alternative Hypothesis:

There is significant change in IBS Severity Score Scale (IBSSSS) using individualized homoeopathic medicine in patients of IBS with a history of adverse parenting.

With the aim to assess the effectiveness of individualized homeopathic medicine in management of patients of IBS associated having a history of adverse parenting.with objective

To determine the change in IBS Severity Score Scale (IBSSSS) using individualized homoeopathic treatment in patients with a history of adverse parenting among IBS patients and

to analyse the types of history of adverse parenting among IBS patients of age group of 18 to 45 years

研究设计

研究类型
Interventional
分配方式
Na
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 45.00 Year(s)(—)
性别
All

入选标准

  • 1.Patients having irritable bowel syndrome according to Rome (IV) criteria.
  • Patients of IBS having history of adverse parenting (Permissive and Authoritarian) according to parenting authority questionnaire (PAQ) which will be also explained.
  • Patients of age between 18-45 years.
  • 4.Patients of all religions, gender and socio-economic conditions.
  • Patients who are literate, willingness to participate in the study and to give written informed consent and if patients are willing but illiterate then they will be explained the importance of the study and consent will be written by physician and thumb impression will be taken.

排除标准

  • Patients who are diagnosed with unstable mental or psychiatric conditions.
  • Patients who are suffering from severe systemic diseases.
  • IBS patients with uncontrolled or life-threatening complications and immune compromised conditions.
  • Pregnant and lactating women.
  • Patients having substance abuse and/or dependence.
  • Patients who are under the treatment homoeopathic medicines, should have minimum wash out period of 2-3months.

结局指标

主要结局

IBS SEVERITY SCORING SYSTEM

时间窗: baseline and 6 months.

次要结局

未报告次要终点

研究者

发起方
Dr Shubhranil Mandal
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr Shubhranil Mandal

National Institute of Homoeopathy

研究点 (1)

Loading locations...

相似试验